Thoughts on Merchant Group establishing a dedicated $250m biotech fund. Andrew Chapman and co have a pretty solid record when it comes to investing in early-stage biotechs.
A dedicated biotech fund taking a position in UBI could be extremely favourable. They'd be particularly interested in UBI's ability to develop rapid cancer detection from a single drop of blood.
https://www.swinburne.edu.au/news/2021/08/researchers-work-to-develop-rapid-cancer-detection-from-a-single-drop-of-blood/
https://www.copyright link/street-talk/merchant-buying-into-biotech-boom-with-250m-fund-20210702-p586f4
UBI General
Add UBI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.5¢ |
Change
0.005(3.33%) |
Mkt cap ! $35.86M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 16.0¢ | 15.5¢ | $34.32K | 218.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 238829 | 15.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 55000 | 2 |
View Market Depth
| Last trade - 14.38pm 29/04/2024 (20 minute delay) ? |
|
|||||
|
Last
15.5¢ |
Change
0.005 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 16.0¢ | 16.0¢ | 15.5¢ | 8496 | ||
| Last updated 12.39pm 29/04/2024 ? | |||||
| UBI (ASX) Chart |